2. Guidelines for surveillance of acute encephalitis syndrome (with special reference to Japanese Encephalitis) [Internet]. Delhi (India): Government of India, Ministry of Health and Family Welfare, Directorate General of Health Services, Directorate of National Vector Borne Diseases Control Programme, 2006;11;cited 2016 Jul 25. Available from:
http://nvbdcp.gov.in/Doc/AES%20guidelines.pdf.
3. Guidelines: Clinical management of acute encephalitis syndrome including Japanese Encephalitis [Internet]. Delhi (India): Government of India, Ministry of Health and Family Welfare, Directorate General of Health Services, Directorate of National Vector Borne Diseases Control Programme, 2009;8;cited 2016 Jul 25. Available from:
http://nvbdcp.gov.in/Doc/Revised%20guidelines%20on%20AES_JE.pdf.
9. Lima JE, Takayanagui OM, Garcia LV, Leite JP. Use of neuron-specific enolase for assessing the severity and outcome in patients with neurological disorders. Braz J Med Biol Res 2004;37:19–26.
11. Kochanek PM, Berger RP, Fink EL, Au AK, Bayır H, Bell MJ, et al. The potential for bio-mediators and biomarkers in pediatric traumatic brain injury and neurocritical care. Front Neurol 2013;4:40
13. Feng BF, Zhu KR. Serum levels of ferritin and neuron-specific enolase in children with hand-foot-mouth disease complicated by acute viral encephalitis. Zhongguo Dang Dai Er Ke Za Zhi 2012;14:515–517.
14. Nguyen DN, Spapen H, Su F, Schiettecatte J, Shi L, Hachimi-Idrissi S, et al. Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit Care Med 2006;34:1967–1974.
15. Wong M, Ess K, Landt M. Cerebrospinal fluid neuron-specific enolase following seizures in children: role of etiology. J Child Neurol 2002;17:261–264.
16. Abd El-Aziz SA, El-Serogy H. Serum neuron-specific enolase: a marker for neuronal injury in children with convulsive status epilepticus. J Pediatr Epilepsy 2012;1:229–235.
17. Correale J, Rabinowicz AL, Heck CN, Smith TD, Loskota WJ, DeGiorgio CM. Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier. Neurology 1998;50:1388–1391.
18. Patel NP, Patel U, Nagpal AC, Jain RK. Evaluating utility of C-reactive protein in differentiating bacterial from non-bacterial meningitis in tertiary care hospital, in Central India. Int J Med Res Rev 2013;1:47–55.
19. Pandey A, Shrivastava AK, Saxena K. Neuron specific enolase and c-reactive protein levels in stroke and its subtypes: correlation with degree of disability. Neurochem Res 2014;39:1426–1432.